FDA Clearance Tracker · P140003-S083
Impella Ventricular Support Systems
Last checked: Nov 20, 2026Latest source record: Jul 13, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jul 13, 2021
Approved
Time to decision
71 days
Received May 3, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140003-S083
- Device name
- Impella Ventricular Support Systems
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- May 3, 2021
- Decided
- Jul 13, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P140003
Device type
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
K241708 · Decided Aug 6, 2024 · 54 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
K221294 · Decided Jun 30, 2023 · 422 days after receipt
Device type: Catheter, Intravascular Occluding, Temporary (MJN) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.